NCT06022822View on ClinicalTrials.gov

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

May 1, 2027

Conditions
Prostate Adenocarcinoma
Interventions
PROCEDURE

Biopsy Procedure

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

DRUG

Placebo Administration

Given PO

DIETARY_SUPPLEMENT

Urolithin A Supplement

Given PO

Trial Locations (5)

27710

RECRUITING

Duke University Medical Center, Durham

53792

RECRUITING

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

60611

RECRUITING

Northwestern University, Chicago

60637

RECRUITING

University of Chicago Comprehensive Cancer Center, Chicago

90048

RECRUITING

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH